secwatch.observer — SEC 8-K summary
======================================

Issuer:     Allarity Therapeutics, Inc. (ALLR)
CIK:        0001860657
Form:       8-K
Filed at:   2023-02-28T23:59:59+00:00
Accession:  0001213900-23-015550
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 3.02, 3.03, 5.03, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Allarity Therapeutics raises $1.2M via Series C Convertible Redeemable Preferred Stock offering
--------------------------------------------------------------------------------

- Sold 50,000 shares of Series C Preferred at $24/share for $1.2M total to an accredited investor.
- Series C carries 5% annual dividend, convertible at lower of $0.182 or market price, floor $0.037.
- Redemption at 110% of stated value ($27) after 60 days up to 365 days from issue.
- Special meeting on March 20, 2023 to seek stockholder approval for authorized share increase and reverse stock split.
- Registration rights agreement requires filing; failure triggers 2% monthly liquidated damages on subscription amount.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1860657/000121390023015550/0001213900-23-015550-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1860657/000121390023015550/ea174273-8k_allarity.htm
  HTML page:      https://secwatch.observer/filing/0001213900-23-015550

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer